We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWH icon
2451
Sportsman's Warehouse
SPWH
$46M
$466K ﹤0.01%
43,565
-2,490
-5% -$27.9K
INDT
2452
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$465K ﹤0.01%
6,358
+783
+14% +$59.8K
ALRS icon
2453
Alerus Financial
ALRS
$828M
$464K ﹤0.01%
16,794
-939
-5% -$27.1K
AUD
2454
DELISTED
Audacy, Inc.
AUD
$464K ﹤0.01%
160,709
-20,744
-11% -$54.8K
HNST icon
2455
The Honest Company
HNST
$586M
$462K ﹤0.01%
88,687
+15,023
+20% +$90.5K
CZNC icon
2456
Citizens & Northern Corp
CZNC
$455M
$459K ﹤0.01%
18,839
-2,134
-10% -$54.1K
GEF.B icon
2457
Greif Class B
GEF.B
$4.21B
$459K ﹤0.01%
7,195
-666
-8% -$39.3K
ICPT
2458
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$459K ﹤0.01%
28,199
-3,832
-12% -$60K
DSGN icon
2459
Design Therapeutics
DSGN
$876M
$457K ﹤0.01%
28,284
+4,995
+21% +$76.5K
SFST icon
2460
Southern First Bancshares
SFST
$600M
$457K ﹤0.01%
8,990
-645
-7% -$37K
IAS
2461
DELISTED
Integral Ad Science
IAS
$456K ﹤0.01%
33,014
+17,470
+112% +$298K
CMRX
2462
DELISTED
Chimerix, Inc.
CMRX
$456K ﹤0.01%
99,511
+57
+0.1% +$318
BGFV
2463
DELISTED
Big 5 Sporting Goods
BGFV
$455K ﹤0.01%
26,520
-1,841
-6% -$32.8K
HY icon
2464
Hyster-Yale Materials Handling
HY
$665M
$455K ﹤0.01%
13,689
-1,270
-8% -$50.2K
TNK icon
2465
Teekay Tankers
TNK
$2.68B
$455K ﹤0.01%
32,864
+5,639
+21% +$68.5K
GIC icon
2466
Global Industrial
GIC
$1.49B
$454K ﹤0.01%
14,079
-95
-0.7% -$3.21K
STRO icon
2467
Sutro Biopharma
STRO
$421M
$454K ﹤0.01%
5,518
-79
-1% -$7.52K
AERI
2468
DELISTED
Aerie Pharmaceuticals
AERI
$451K ﹤0.01%
49,583
+1,157
+2% +$8.92K
ATRO icon
2469
Astronics
ATRO
$3.84B
$449K ﹤0.01%
41,698
-3,376
-7% -$36.7K
CCB icon
2470
Coastal Financial
CCB
$693M
$449K ﹤0.01%
9,816
+370
+4% +$18K
YELL
2471
DELISTED
Yellow Corporation Common Stock
YELL
$449K ﹤0.01%
64,099
+4,035
+7% +$38.5K
IDYA icon
2472
IDEAYA Biosciences
IDYA
$3.56B
$447K ﹤0.01%
39,982
+1,835
+5% +$27K
CSTR
2473
DELISTED
CapStar Financial Holdings, Inc
CSTR
$446K ﹤0.01%
21,158
-2,135
-9% -$45.7K
BWB icon
2474
Bridgewater Bancshares
BWB
$603M
$445K ﹤0.01%
26,684
-1,978
-7% -$34.5K
FNKO icon
2475
Funko
FNKO
$328M
$445K ﹤0.01%
25,819
+1,768
+7% +$30.9K

Similar funds

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.